Quick Answer
NRX Pharmaceuticals, Inc. reported Total Assets of $12.96 million for fiscal year 2025.
NRX Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $12.96M | +254.9% |
| 2024 | $3.65M | -50.1% |
| 2023 | $7.32M | -71.7% |
| 2022 | $25.82M | -21.1% |
| 2021 | $32.73M | +1012.9% |
| 2020 | $2.94M | -90.8% |
| 2019 | $32.07M | -54.7% |
| 2018 | $70.80M | +1.8% |
| 2017 | $69.57M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $15.00M | +236.1% | +210.0% |
| June 30, 2025 | $4.84M | -8.1% | -36.3% |
| March 31, 2025 | $7.59M | +100.4% | +107.9% |
| December 31, 2024 | $3.65M | -50.1% | -18.2% |
| September 30, 2024 | $4.46M | -66.0% | -15.2% |
| June 30, 2024 | $5.26M | -73.4% | +39.0% |
| March 31, 2024 | $3.79M | -82.6% | -48.2% |
| December 31, 2023 | $7.32M | -71.7% | -44.2% |
- NRX Pharmaceuticals, Inc. showed an increase of +254.9% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, NRX Pharmaceuticals, Inc.’s total assets has declined by 81.4% (from $69.57 million to $12.96 million).
- The most recent figure is from NRX Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: